+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Public Health Benefits of Routine Human Papillomavirus Vaccination for Adults in the Netherlands: A Mathematical Modeling Study



Public Health Benefits of Routine Human Papillomavirus Vaccination for Adults in the Netherlands: A Mathematical Modeling Study



Journal of Infectious Diseases 214(6): 854-861



Expanding routine human papillomavirus (HPV) vaccination to adults could be an effective strategy to improve prevention of HPV infection and cervical cancer. We evaluated the following adult vaccination strategies for women only and for both women and men in addition to the current girls-only vaccination program in the Netherlands, using the established STDSIM microsimulation model: one-time mass campaign, vaccination at the first cervical cancer screening visit, vaccination at sexual health clinics, and combinations of these strategies. The estimated impact of expanding routine vaccination to adult women is modest, with the largest incremental reductions in the incidence of HPV infection occurring when offering vaccination both at the cervical cancer screening visit and during sexually transmitted infection (STI) consultations (about 20% lower after 50 years for both HPV-16 and HPV-18). Adding male vaccination during STI consultations leads to more-substantial incidence reductions: 63% for HPV-16 and 84% for HPV-18. The incremental number needed to vaccinate among women is 5.48, compared with 0.90 for the current vaccination program. Offering vaccination to adults, especially at cervical cancer screening visits (for women) and during STI consultations (for both sexes), would substantially reduce HPV incidence and would be an efficient policy option to improve HPV prevention and subsequently avert cervical and possibly male HPV-related cancers.

(PDF emailed within 0-6 h: $19.90)

Accession: 058661133

Download citation: RISBibTeXText

PMID: 27330051

DOI: 10.1093/infdis/jiw256


Related references

The health impact of human papillomavirus vaccination in the situation of primary human papillomavirus screening: A mathematical modeling study. Plos One 13(9): E0202924, 2018

Doubts on the appropriateness of universal human papillomavirus vaccination: is evidence on public health benefits already available?. Journal of Epidemiology and Community Health 62(8): 667, 2008

The impact of a human papillomavirus (HPV) vaccination campaign on routine primary health service provision and health workers in Tanzania: a controlled before and after study. Bmc Health Services Research 18(1): 173, 2018

The Public Health Benefits and Economic Value of Routine Yellow Fever Vaccination in Colombia. Value in Health Regional Issues 20: 60-65, 2019

The Digital Distribution of Public Health News Surrounding the Human Papillomavirus Vaccination: A Longitudinal Infodemiology Study. Jmir Public Health and Surveillance 1(1): E2, 2015

Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. Bmc Infectious Diseases 13: 75, 2013

Health and economic benefits of early vaccination and nonpharmaceutical interventions for a human influenza A (H7N9) pandemic: a modeling study. Annals of Internal Medicine 160(10): 684-694, 2014

How can we increase offer rates of human papillomavirus (HPV) vaccination among men who have sex with men (MSM) in routine sexual health clinics?. Sexually Transmitted Infections 94(4): 247, 2018

Dutch public health experts refute claims that human papillomavirus vaccination has health risks. Bmj 338: B1109, 2009

Health and Economic Impact of a Tender-Based, Sex-Neutral Human Papillomavirus 16/18 Vaccination Program in the Netherlands. Journal of Infectious Diseases 216(2): 210-219, 2017

Vaccination for human papillomavirus, part 2: public health aspects. Cutis 80(6): 460, 483, 2008

The potential health and economic benefits of preventing recurrent respiratory papillomatosis through quadrivalent human papillomavirus vaccination. Vaccine 26(35): 4513-4518, 2008

Social Determinants of Health and Human Papillomavirus Vaccination Among Young Adults, National Health Interview Survey 2016. Journal of Community Health 2018, 2018

Simultaneously characterizing the comparative economics of routine female adolescent nonavalent human papillomavirus (HPV) vaccination and assortativity of sexual mixing in Hong Kong Chinese: a modeling analysis. Bmc Medicine 16(1): 127, 2018

Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health. Public Health Genomics 12(5-6): 319-330, 2009